Extracellular matrix-driven metabolic control of pancreatic endocrine lineage allocation.
EMBO Rep., 28 (2025)
The mechanical and metabolic states of progenitor and stem cells are emerging as key regulators of cell fate decisions. Lineage specification of pancreatic endocrine cells is promoted by reduced mechanical tension in vitro, but the underlying mechanism is poorly understood. Here, we show that heterogeneously deposited low-adhesion extracellular matrix (ECM) components, such as the laminin isoform LN411, trigger a local "soft" environment by broadly reducing the expression of integrins. Mimicking this low-tension state by in vitro knockdown and in vivo gene targeting of the LN-binding integrins Itga3 and Itga6 reveal their importance in inducing endocrinogenesis. Unexpectedly, the cell responds to this change in tensile forces by engaging a major metabolic enzyme, PDK4, to execute the resulting cell fate decision. PDK4 achieves this through two distinct mechanisms: a non-canonical action controlling YAP activity and a canonical metabolic function maintaining PDX1 expression. In sum, we believe our findings have broad relevance for how local changes in mechanical tension governs cell behaviour in many developmental and disease contexts.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Laminin-411 ; Mechanotransduction ; Pdk4 ; Pancreatic Endocrinogenesis ; Yap Signalling; Pluripotent Stem-cells; Differentiation; Fate; Pdx1; Transcription; Reveals; Network; Yap; Organogenesis; Expression
Keywords plus
Language
english
Publication Year
2025
Prepublished in Year
0
HGF-reported in Year
2025
ISSN (print) / ISBN
1469-221X
e-ISSN
1469-3178
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: ,
Issue: ,
Pages: 28
Article Number: ,
Supplement: ,
Series
Publisher
EMBO Press
Publishing Place
Campus, 4 Crinan St, London, N1 9xw, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-506800-001
Grants
European Union
Novo Nordisk Foundation Center for Stem Cell Biology (DanStem)
Helmholtz Zentrum Munchen
Copyright
Erfassungsdatum
2025-10-29